Peter L. Johansson
Haematology Section
Department of medicine
Sahlgrenska University hospital
Göteborg
Sweden
Name/email consistency: high
- Epidemiology of the myeloproliferative disorders polycythemia vera and essential thrombocythemia. Johansson, P. Semin. Thromb. Hemost. (2006)
- Hydroxyurea therapy increases plasma erythropoietin in patients with essential thrombocythaemia or polycythaemia vera. Johansson, P., Andréasson, B. Clin. Lab. Haematol (2006)
- An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia. Johansson, P.L., Safai-Kutti, S., Kutti, J. Br. J. Haematol. (2005)
- Oxygen affinity is decreased in patients with polycythaemia vera and essential thrombocythaemia. Johansson, P., Brudin, G., Nilsson, B., Andréasson, B. Scand. J. Clin. Lab. Invest. (2004)
- The presence of a significant association between elevated PRV-1 mRNA expression and low plasma erythropoietin concentration in essential thrombocythaemia. Johansson, P., Andréasson, B., Safai-Kutti, S., Wennström, L., Palmqvist, L., Ricksten, A., Lindstedt, G., Kutti, J. Eur. J. Haematol. (2003)
- On the diagnosis of polycythaemia vera as assessed in the health and medical care in the Västra Götaland region, Sweden. Johansson, P., Andréasson, B., Safai-Kutti, S., Rhedin, C., Vilén, L., Väärt, J., Kutti, J. J. Intern. Med. (2002)









